REVMATOLOGICK STAV
A United Kingdom buyer, with 6 published contracts, worth £263.6m, most recently 6 months ago.
Top 4 suppliers won 100% of awarded value — £218.0m of £218.0m across 4 awards.
This contract involves the ongoing supply of medications as outlined in Appendix 1 of the Purchase Agreement – Price Offer. The supplies must include the pharmaceutical product Denosumab (M05BX04) in accordance with the tender conditions.
This contract involves the ongoing supply of the medication Etanercept (L04AB01) as detailed in Appendix 1 of the Purchase Agreement – Price Offer. Suppliers are expected to deliver these pharmaceutical products in accordance with the specified procurement conditions.
